Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 96. Johnson P N, Miller J L, Hagemann T M, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. The Annals of pharmacotherapy. 2014; 48 : 187-95
97. Miller J L, Schaefer J, Tam M, Johnson P N. Ethacrynic acid continuous infusions in critically-ill pediatric patients. Journal of Pediatric Pharmacology and Therapeutics. 2014; 18 : 167
98. Johnson P N, Benefield E C, Bui P N, Marlar R A, Gessouroun M R. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. Journal of Pediatric Pharmacology and Therapeutics. 2013; 18 : 303-310
99. Johnson P N, Benefield E C, Bui P N, Gausman J N, Marlar R A, Gessouroun M R. Fondaparinux monitoring: Need for a local fondaparinux-calibrated anti-factor Xa assay. Journal of Pediatric Pharmacology and Therapeutics. 2013; 18
100. Rathbun C, Cottrell M L, Johnson P N, Lockhart S M. Implications for Hepatitis C Treatment and Disease Progression in an HIV/HCV Co-Infected Population. Journal of Virology and Antiviral Research. 2013; 2 : 3
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2016.
7. Pediatric Pharmacy Advocacy Group. Best Student Investigator Award (Served as student mentor). Date: 2015.
8. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.
9. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.
10. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results